Stock listing
Rapport Therapeutics, Inc.
Selected listing: RAPP · NASDAQ · USD · US
Rapport Therapeutics, Inc. (NASDAQ:RAPP), Health Technology. Latest release Aug 24, 2026: Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need…
- Ticker
- NASDAQ:RAPP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Rapport Therapeutics, Inc.
The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its dedicated public company page.
Latest news from Rapport Therapeutics, Inc.
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
August 24, 2026
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
August 5, 2026
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
May 20, 2026
Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update
May 7, 2026
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
April 21, 2026
Research Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. company profile
View the public company page for Rapport Therapeutics, Inc. on 6ix.
Rapport Therapeutics, Inc. news
Read company news and market updates connected to Rapport Therapeutics, Inc..
Rapport Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Rapport Therapeutics, Inc..